Comparison of Prices and Affordability of Cancer Medicines in 16 Countries in Europe and Latin America.

ABSTRACT:

Background

There are concerns that high prices of cancer medicines may limit patient access. Since information on prices for cancer medicines and their impact on affordability is lacking for several countries, particularly for lower income countries, this study surveys prices of originator cancer medicines in Europe and Latin America and assesses their affordability.

Methods

For 19 cancer medicines, public procurement and ex-factory prices, as of 2017, were surveyed in five Latin American (LATAM) countries (Brazil, Chile, Colombia, Mexico, and Peru) and 11 European countries (Austria, France, Germany, Greece, Hungary, the Netherlands, Poland, Romania, Spain, Sweden, and the UK). Price data (public procurement prices in LATAM and ex-factory prices in Europe) in US dollar purc

SUBMITTER: Moye-Holz D 

PROVIDER: S-EPMC8752537 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature